In human PCLS from COPD patients, treatment with fibroblast growth factor 10 (FGF10) increased cellular proliferation, as characterised by number of BrdU + stained cells, though no proliferating cells were found in the tunica media of the pulmonary arteries [87]. Here, FGF10 is linked to chronic obstructive pulmonary disease.